Roger Armen

Advisor at AltPep

Dr. Armen is an Assistant Professor of Pharmaceutical Sciences at the Medical School of Thomas Jefferson University. He is an expert in medicinal chemistry and computational drug design. Roger is Co-discoverer of the α-sheet structure in the Daggett Research Group.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


AltPep

AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).


Industries

Employees

11-50

Links